Home
Activity Overview
Activity Overview
RP1 with nivolumab elicited an ORR of 38.7% with an acceptable safety profile in patients with advanced melanoma who progressed on anti–PD-1 therapy.
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
SAN ANTONIO — The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with breast cancer, according to data presented at…
Prevention averts death (by Nick Youngson via The Blue Diamond Gallery)Cancer prevention, screening and treatment efforts have averted an estimated 5.94 million deaths in the…
Before starting any type of treatment, a patient may consider getting a second opinion–especially if some characteristics of the diagnosis are complicated or uncertain.
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems
The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services Office of Human Research Protections issued Draft Guidance on the…
Annals of Surgical Oncology – Dumping syndrome occurs frequently after esophageal cancer surgery, but the reported prevalence varied across previous studies. This systematic review and…
Abstract. The risk of gastric cancer among immigrants from countries where Helicobacter pylori is endemic greatly exceeds those born in the United States. Among patients…